August 2025
1. PHAM TP, Pham HT, Doan PM, Hoang NA, et al
   Structural equation modelling of nucleotide polymorphisms and pharmacokinetics in direct oral anticoagulant use for stroke and embolism prevention in atrial fibrillation.
   Eur J Pharmacol. 2025;1005:178049.
   

   >> Share

   
   July 2025
2. CHEN J, Zhang W, Li Z, Hu T, et al
   Pyridostigmine Improves Post-Resuscitation Myocardial Dysfunction in a Rat Model of Ventricular Fibrillation-Induced Cardiac Arrest and Resuscitation.
   Eur J Pharmacol. 2025 Jul 10:177917. doi: 10.1016/j.ejphar.2025.177917.
   

   >> Share

   
   June 2025
3. LI Y, Sun J, Li X, Yu W, et al
   Donepezil-induced degradation of hERG potassium channel via lysosomal pathway is exacerbated by hypoxia.
   Eur J Pharmacol. 2025;996:177549.
   

   >> Share

   
   April 2025
4. LI TL, Zhu NN, Zhao MX, Sun J, et al
   Omentin-1 attenuates atrial fibrillation via Src/PI3K/Akt signaling-mediated anti-fibrotic effects in cardiac fibroblasts.
   Eur J Pharmacol. 2025;996:177588.
   

   >> Share

   
   March 2025
5. LIU GX, Diao F, Lu G, Zheng Q, et al
   Alectinib causes sinus bradycardia by suppressing L-type calcium current in sinus node.
   Eur J Pharmacol. 2025 Mar 19:177527. doi: 10.1016/j.ejphar.2025.177527.
   

   >> Share

   
   January 2025
6. PAN QM, Bi FF, Jing ZH, Cao M, et al
   A New target of ischemic ventricular arrhythmias-ITFG2.
   Eur J Pharmacol. 2025 Jan 24:177301. doi: 10.1016/j.ejphar.2025.177301.
   

   >> Share

   
   August 2024
7. HU HJ, Wang XH, Zhang ZZ, Ou Y, et al
   SIRT3 sulfhydration using hydrogen sulfide inhibited angiotensin II-induced atrial fibrosis and vulnerability to atrial fibrillation via suppression of the TGF-beta1/Smad2/3 signalling pathway.
   Eur J Pharmacol. 2024 Aug 19:176900. doi: 10.1016/j.ejphar.2024.176900.
   

   >> Share

   
   
8. ZHANG Y, Li R, Jiang H, Hou Y, et al
   Salidroside modulates repolarization through stimulating Kv2.1 in rats.
   Eur J Pharmacol. 2024;977:176741.
   

   >> Share

   
   
9. LIU CM, Lin FJ, Chhay C, Chen YC, et al
   Ibrutinib, a Bruton's tyrosine kinase inhibitor, regulates ventricular electromechanical activities and enhances arrhythmogenesis.
   Eur J Pharmacol. 2024;977:176675.
   

   >> Share

   
   June 2024
10. ZHAN G, Wang X, Wang X, Li J, et al
    Dapagliflozin: A sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced atrial fibrillation by regulating atrial electrical and structural remodeling.
    Eur J Pharmacol. 2024;978:176712.
    

    >> Share

    
    
11. SONG S, Yuan J, Fang G, Li Y, et al
    BRD4 as a Therapeutic Target for Atrial Fibrosis and Atrial Fibrillation.
    Eur J Pharmacol. 2024 Jun 5:176714. doi: 10.1016/j.ejphar.2024.176714.
    

    >> Share

    
    November 2023
12. LI F, Qian LL, Wu LD, Zhang ZY, et al
    Glucose fluctuations aggravated the late sodium current induced ventricular arrhythmias via the activation of ROS/CaMKII pathway.
    Eur J Pharmacol. 2023 Nov 6:176167. doi: 10.1016/j.ejphar.2023.176167.
    

    >> Share

    
    
13. YI Y, Tianxin Y, Zhangchi L, Cui Z, et al
    Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
    Eur J Pharmacol. 2023;960:176169.
    

    >> Share

    
    October 2023
14. DE LIMA CONCEICAO MR, Teixeira-Fonseca JL, Marques LP, Souza DS, et al
    Interaction of the antiarrhythmic drug Amiodarone with the sodium channel Na(v)1.5 depends on the extracellular pH.
    Eur J Pharmacol. 2023 Oct 17:176127. doi: 10.1016/j.ejphar.2023.176127.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share